FGFR3 and neoplasm: However, FGFR3 alterations were closely associated with lower pT stage, tumor grade, and other favorable clinical features and outcomes (54), altogether, it was highly recommended that UC patients with FGFR3-altered tumors would be more likely to benefit from anti-FGFR3 therapy.